Peter Handrinos practices corporate and securities law, with an emphasis on mergers and acquisitions, capital markets and venture capital transactions for life sciences and technology companies. Mr. Handrinos advises both public and private companies in connection with a broad range of matters, including:
- Follow-on offerings
- Strategic investments
- 144A offerings
- Cash and stock mergers
- Tender offers
- Going-private transactions
He counsels numerous start-up companies and venture capital firms in venture capital financings. Mr. Handrinos also regularly represents investment banks in connection with capital markets transactions. A significant portion of his practice involves general corporate work for ongoing clients on matters such as SEC compliance, securities and disclosure issues, and corporate governance matters.
The Legal 500 USA described Mr, Handrinos as “one of the best life sciences lawyers in Boston.” He has been recognized as a leader in Corporate/M&A by Chambers USA since 2007, where he is also described as a “superb attorney – exceptionally bright, attentive to details and remarkably hard working.” He has been listed in the 2012 and 2014 editions of Best Lawyers in America as a leader in mergers and acquisitions.
Mr. Handrinos's representative transactions includes advising: